The release of finalized FDA guidance on electronic submissions of de novo requests to the agency for medical devices is “one of several steps in meeting FDA’s commitment to the development of electronic submission templates to serve as guided submission preparation tools for industry to improve submission consistency and enhance efficiency in the review process,” the FDA said... Read More